Tesamorelin is a growth-hormone-releasing analog that can increase IGF-1 levels in both men and women. Tesamorelin was approved for use in the United States as therapy to reduce excess abdominal fat. Tesamorelin is also being evaluated as therapy of insulin resistance, obesity and nonalcoholic fatty liver. Tesamorelin may also improve cognitive function for people with old age, and patients who suffer increase risk in Alzheimer’s disease due to mild cognitive impairment.

Science-Backed Research

• Increase in the release of endogenous growth hormone
• Promotes muscle growth
• Helps with mood and stress resilience
• Slows down aging
• Enhances metabolic rate
• Improves sleep
• Promotes a balanced inflammatory response
• Improves bone density

Disclaimer: This peptide is for research and educational purposes only. It is not intended for diagnostic or therapeutic use without the guidance of a qualified healthcare professional.